Ali, Mir Khader

Extended Follow up of a Phase 2 Study of Ibrutinib in Hairy Cell Leukemia

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6494-6495

10.1182/blood-2022-165795